Your Account
Sort
Categories
- #EMSPVirtual2021
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- News2
- Press Releases
- Project Updates
- Stakeholder Events
- Uncategorized
- Young People with MS
Defining the Best Patient Group for IMMUTOL’s New Cell Therapy: MS Patients Speak Out
On 25 November 2025, European Multiple Sclerosis Platform (EMSP) organised a consultation between the Multiple Sclerosis Community Advisory Board (MSCAB),…
2025: A Year of Solidarity, Progress, and Collective Strength
As we close the chapter on 2025, we reflect on an extraordinary year for our community—one marked by historic wins,…
How Brain Imaging and Motion Sensors Are Unlocking Potential For Personalised MS Rehabilitation
For many people living with multiple sclerosis, walking becomes increasingly difficult over prolonged periods due to a phenomenon called “walking…
Urgent call for a Ringfenced, Standalone Health Budget for Europe
COVID-19 taught us a powerful lesson: without health, there is no resilience, no productivity, no future. Yet as the EU…
From Insight to Action: Bridging the MS experience gap
Over a million people live with multiple sclerosis (MS) in Europe today, a condition that is debilitating, complex, and varied…
5 Years of advocacy for NMOSD and MOGAD: A milestone for the Netherlands, an opportunity for Europe
Guest article contributed by Mieke Bakker, Dutch NMO/MOGAD Working Group The Dutch NMOSD/MOGAD working group celebrates its fifth anniversary Five…
